Retinoic acid influences the development of the inferior olivary nucleus in the rodent  by Yamamoto, Miyuki et al.
www.elsevier.com/locate/ydbioDevelopmental BiologyRetinoic acid influences the development of the inferior olivary nucleus
in the rodent
Miyuki Yamamotoa,1, Masahiro Fujinumaa,1, Shinji Hiranob, Yoshika Hayakawaa,
Margaret Clagett-Damec, Jinghua Zhangd, Peter McCafferyd,T
aInst. Basic Medical Sciences, University of Tsukuba, Tennodai 1-1-1, Tsukuba, Ibaraki 305-8575, Japan
bRIKEN Center for Developmental Biology, Chuou-ku, Kobe 650-0047, Japan
cDepartment of Biochemistry, University of Wisconsin-Madison, Madison, WI 53706-1544, USA
dUMMS/E.K. Shriver Center, 200 Trapelo Road, Waltham, MA 02452, USA
Received for publication 11 November 2004, revised 2 February 2005, accepted 7 February 2005Abstract
All-trans retinoic acid (atRA) is an endogenous morphogen that regulates gene transcription. Maternal exposure to atRA results in severe
developmental abnormalities by disrupting normal patterns of atRA distribution. Previously, we have shown that the pontine nucleus, which
originates from the rhombic lip, is severely atrophied in the mouse on exposure to atRA at gestational days 9 and 10. In this study, we show
that this same period of atRA exposure has the contrary effect on the inferior olive and this rhombic lip derivative is expanded in volume and
probably contains an increased number of cells. The posterior region of the inferior olive maintains a relatively normal shape but is
significantly expanded in size. In contrast, the organization of the anterior inferior olive is severely disrupted. Because endogenous atRA
levels are known to be higher in the region of the posterior inferior olive at the time of birth of inferior olivary neurons, these results suggest
that endogenous atRA may promote the generation, or select the fate, of posterior neurons of the inferior olive. In support of this concept, a
reduction in atRA resulting from vitamin A deficiency results in loss of cells of the posterior inferior olive.
D 2005 Elsevier Inc. All rights reserved.
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All-trans retinoic acid (atRA) regulates gene expression
in the developing nervous system by activating specific
receptors that are members of the nuclear receptor super-
family of transcriptional regulators (Bastien and Rochette-
Egly, 2004; Maden, 2002). The influence of atRA on the
early nervous system has been well studied in the formation
of the anteroposterior axis of the neural tube (Durston et al.,
1989; Thaller and Eichele, 1987; Tickle et al., 1982).
Compelling evidence points to an essential role for atRA in0012-1606/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
doi:10.1016/j.ydbio.2005.02.007
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E-mail address: peter.mccaffery@umassmed.edu (P. McCaffery).
1 These authors contributed equally to this work.the determination of the segmental pattern of the posterior
hindbrain (Dupe and Lumsden, 2001; Dupe et al., 1999;
Kolm et al., 1997; Maden et al., 1996; Marshall et al., 1992;
Morris-Kay et al., 1991; Niederreither et al., 2000; Sakai et
al., 2001; van der Wees et al., 1998; White et al., 2000b). A
function for atRA at later stages of hindbrain development
has been proposed in the mouse (Parenti and Cicirata, 2004;
Yamamoto et al., 1998, 1999, 2003) and recently in
zebrafish (Begemann et al., 2004; Linville et al., 2004). In
the mouse, this atRA may be provided by the synthetic
enzyme RALDH2 in the meninges (Zhang et al., 2003). One
set of neurons that may be regulated by atRA are those that
make up the cerebellar system. During development of the
cerebellar system, the precursors of cerebellar neurons and
the precerebellar nuclei that send afferents to the cerebellum
lie within the dorsal rhombic lip (Altman and Bayer, 1987;280 (2005) 421–433
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migrate ventrally to their appropriate positions. The subset
of these neurons that migrate circumferentially under the
meninges and over the surface of the hindbrain are
constantly exposed, and respond, to atRA (Zhang et al.,
2003). It would be predicted that excess amounts of atRA at
the wrong time, place, or concentration would result in
aberrant development. Certainly, exposure to 13-cis RA
during human pregnancy results in malformation of the
cerebellum as well as the pontine nucleus and the inferior
olivary nucleus (IO) (Lammer and Armstrong, 1992) and
the 13-cis isomer of RA likely acts through its isomerization
to atRA (Nau, 2001). Likewise, in rats, the cerebellum and
inferior olive are both sensitive to atRA exposure (Holson
et al., 1997a,b).
We have previously shown in mice that the neurons that
migrate around the exterior of the hindbrain to form the
pontine nuclei are highly sensitive to teratogenic atRA, which
disrupts their migratory pathway resulting in the loss of these
nuclei (Yamamoto et al., 2003). In this study, we focus on the
effects of atRA on the developing inferior olive, the
progenitors of which migrate along a submarginal stream
(Bourrat and Sotelo, 1988). Contrary to atRA’s effect on the
pontine nuclei, we show that atRA can increase the size of the
IO when treatment is at gestational days 9 and 10,
preferentially acting on the posterior IO. This may reflect
the high endogenous atRA levels of the posterior hindbrain
(Smith et al., 2001; Zhang et al., 2003) and possibly a normal
requirement of the posterior IO for these amounts of atRA.Materials and methods
Animals and atRA treatment
C57Bl6 pregnant mice were purchased from SLC
(Tokyo, Japan). The day when the plug was confirmed
was designated as gestation day 0. A stock solution of 0.1 M
atRAwas prepared in DMSO and diluted in SFM101 culture
medium (Nissui) with 10% FCS in 1:10 ratio. Diluted atRA
solution (30 mg/kg b.w.) was injected intraperitoneally on 1
day—embryonic days 8, 9, or 10, or on two consecutive
days—embryonic days 9/10, 10/11, 12/13, 14/15, and 16/
17, or for 5 days—12–17. At embryonic day 18, the animals
were deeply anesthetized with ether and decapitated and the
embryos removed. Controls consisted of either DMSO
injected animals (with the DMSO dissolved in the same
vehicle at 1:10 dilution) or untreated animals. This research
conformed to the stipulations of the animal experimental
committee of the University of Tsukuba and the University
of Massachusetts Medical School.
Histology
Brains of embryonic day 18 embryos were fixed in 4%
paraformaldehyde, embedded in paraffin, or embedded inagarose (2.3%), cut into serial sections (5 Am for paraffin
and 100 Am for agarose), and stained with cresyl violet.
The brainstem and the cerebellum were examined
histologically.
The wet weight of the brain was measured from the
posterior edge of the olfactory bulb to the anterior edge of
the C1 nerve root. To measure the volume of the IO, it was
traced by using a camera lucida on each section. The surface
area of the traced IO from every section was measured. The
total volume of the IO nucleus was calculated as the total
surface area  0.1 mm (thickness of a section).
Measurement of the cell density of the IO
To determine the average cell density through the IO, a
single embryonic brain from each injection schedule was
embedded in paraffin, cut in 5 Am sections, and analyzed
every 100 Am. The border of the IO was traced and the
surface area was measured in these sections and the total
neuronal number was counted within the circumference of
the IO by the dissector method (Coggeshall and Lekan,
1996) at 40 magnification. Only neurons that had
nucleoli were counted. The density was calculated for
each section as the total neuronal number contained within
the outline of the IO, divided by the area of IO, and the
average was determined for all counted sections of each
embryo.
For all statistical analysis, the Student’s t test was used
with P b 0.01 or P b 0.05 values considered significant.
DIG-RNA labeling
Mouse OL-protocadherin (Hirano et al., 1999), and
human Brn 3a probes (a gift from Dr. Mengqing Xiang,
UMDNJ-Robert Wood Johnson Medical School, NJ) were
labeled following the method described in the Boehringer-
Mannheim DIG labeling kit. The final concentrations of the
probes were 0.47–1 ng/ml.
For whole mount in situ hybridization, embryonic brains
were fixed in 4% paraformaldehyde in PBS (pH7.5)
overnight and stored in 100% methanol at 208C for up
to 3 weeks until use. Brains were placed in PBS with 0.1%
Tween-20 (PBT), transferred through a methanol gradient
(75%, 50%, 25% in PBT), and treated with proteinase K
(Boehringer-Mannheim) (10 mg proteinase K/ml PBT) for
15 min. This was followed by incubation with 2 mg glycine/
ml PBT for 10 min, a PBT wash (2  5 min), and re-
fixation with 4% paraformaldehyde and 0.2% glutaralde-
hyde in PBS. After the PBT wash, each sample was
prehybridized with 1 ml of 50% formamide 25% 20 SSC
(pH4.5), 1% SDS with 50 mg yeast RNA/ml and 50 mg
Heparin/ml for 1 h at 708C, followed by incubation with
hybridization solution (prehybridization buffer plus DIG-
labeled RNA probe (1 mg/ml) overnight at 708C. Samples
were then washed with solution 1(50% formamide, 1%
SDS, 25% 20 SSC (pH4.5), in d.w.) 3  30 min at 708C
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(pH4.5), in d.w.) 3  30 min at 658C, followed by a 3  5
min PBT wash at RT.
Samples were preblocked with 10% Normal Goat Serum
(Chemicon) in PBT for 1–3 h and incubated with alkaline
phosphatase (AP) conjugated anti-digoxigenin antibody
(Fab fragments, Boehringer-Mannheim) (1 Al/mlPBT/sam-
ple) preabsorbed with mouse embryonic powder. For the
wash with TBST (0.8% NaCl, 0.02% KCl, 25 mM Tris–HCl
pH7.5, 2 mM Levamisole, 0.1% Tween-20), the solution
was changed every hour, 8–10 times at RT, and rocked
overnight at 48C. To visualize AP reaction, samples were
incubated with NTMT (100 mM NaCl, 100 mM Tris–HCl
pH 9.5, 50 mM MgCl2, 0.1% Tween-20, 2 mM Levamisole)
3  10 min, then with BM Purple (Boehringer-Mannheim)
for 20 min to 2 h in the dark. The reaction was stopped with
10 mM Tris–HCl pH 7.5, 1 mM EDTA, 0.9% NaCl and the
samples were stored in 4% paraformaldehyde (modified
from (Riddle et al., 1993)).
For section in situ hybridization, the sections were first
hydrated in 100%, 90%, 75%, and 50% ethanol and then 2
SSC for 1 min each. Sections were treated with proteinase K
10 mg/ml in 100 mM Tris (pH8.0) with 50 mM EDTA at
378C for 8–10 min, rinsed in d.w., and incubated with 0.1 M
triethanolamine with acetic anhydride for 10 min, followed
by dehydration through an ethanol gradient and air-dried for
1 h. Hybridization solution was composed of 50%
formamide, 10% dextran sulfate, 1% blocking solution
(Boehringer-Mannheim), 7.2% of TEN buffer (5 ml; 1.0 M
Tris pH 7.5, 30 ml; 5 M NaCl, 1 ml; 0.5 M EDTA) with
DIG-RNA probe (0.47–1 ng/ml) boiled 10 min at 688C and
cooled on ice.
Hybridization solution was placed on sections (1 ng/80
Al/each slide), sealed with DPX mount (Fluka), and
incubated at 558C overnight. After incubation, DPX mount
was peeled off and sections were soaked in 2 SSC until
the coverslips separated from the slides. The slides were
washed in 2 SSC for 5 min at RT followed by a wash in
50% formamide in 2 SSC at 558C for 30 min and rinsing
twice in 2 SSC at 378C for 10 min. 20 mg/ml of RNaseA
was added and slides were incubated for 30 min at 378C and
washed in 558C RNase buffer for 30 min. For immunocy-
tochemical detection of DIG, slides were preincubated with
2 SSC with 0.05% Triton X-100 and 1% blocking buffer
(from Boehringer-Mannheim Genius kit 3) for 1–2 h at RT.
After washing with maleate buffer (0.1 M, pH 7.5) 3 for
10 min, the slides were incubated with alkaline phosphatase
labeled anti-DIG antibody (1:1000 in maleate buffer with
1% blocking reagent and 0.3% Triton X-100) overnight at
48C. After washing in maleate buffer followed by alkaline
phosphatase buffer (0.1 M Tris pH 9.5, 0.1 M NaCl and 50
mM MgCl2) 3 times each for 10 min, the sections were
reacted with BM purple (Boehringer-Mannheim) for 1–5 h
at RT. After the reaction was stopped with 10 mM Tris pH
7.5, 1 mM EDTA, 0.9% NaCl for 30 min, sections were
mounted in glycerol.Generation of Vitamin A-deficient rats embryos
It is difficult to generate vitamin A-deficient mice
because of their efficient use and storage of vitamin A.
Embryonic vitamin A deficiency models however have
been well defined in the rat (Clagett-Dame and DeLuca,
2002). Rats were rendered vitamin A-deficient (VAD) from
weaning at 20–21 days, employing a purified diet devoid
of vitamin A activity (Suda et al., 1970) but supplemented
with vitamins D, E, and K (Council, 1995). The animals
were maintained on this diet for 70–120 days before the
first signs of deficiency were evident. When symptoms of
vitamin A deficiency appeared (body weight plateau and
xerophthalmia), the animals were supplemented with atRA
at 12 Ag/g diet and mated as described (White et al.,
1998).
The vitamin A-deficient pregnant rats were maintained
on an atRA sufficient diet of 12 Ag/g atRA up to
embryonic day 8.5. Dietary atRA was then increased to
250 Ag/g between embryonic day 8.5 to 10.5, which is
essential for heart development over that period (White et
al., 2000a). After this period, atRA was reduced to 1.5 Ag
atRA/g diet to examine the effects of vitamin deficiency on
hindbrain development. The control vitamin A-sufficient
(VAS) pregnant rats were treated in one of two ways,
either receiving vitamin A (retinyl palmitate, 500 units/
day) together with 12 Ag/g atRA in the diet from
embryonic day 0.5 (VAS #1); alternatively, to match the
250 Ag/g pulse of atRA used in the VAD treatment, a
second control was used in which the rats were treated
with 12 Ag/g atRA in the diet from embryonic day 0.5 to
8.5 (VAS #2). This was followed by 250 Ag/g of atRA
between embryonic day 8.5 to 10.5 and retinyl palmitate
from embryonic day 10.5 onwards.Results
Morphological change
To determine the critical period for atRA’s interference
with IO development, atRA was injected i.p. at 30 mg/kg
into pregnant dams at a range of gestational time points,
and the embryos examined at embryonic day 18. The
number of animals used for each experiment is shown in
Table 1.
Embryonic day 8 injection
The total brain weight (from olfactory bulb to the level
of the exit of the C1 nerve) was smaller than the controls
(Fig. 1). Furthermore, the length of the medulla in the
anteroposterior axis appeared shorter than normal (Fig. 2)
and therefore the relative ratio of anterior to posterior
length of the IO versus the whole medulla seemed larger
than normal. However, despite this significant alteration in
the morphology of the medulla, the overall structure of the
Table 1
Number of pregnant animals and embryos used at each period of atRA treatment
Injection day E8 E9/10 E10/11 E12/13 E14/15 E16/17 E12–17
RA injection 3 (13) 4 (32) 3 (21) 4 (23) 2 (16) 2 (19) 5 (17)
DMSO injection 1 (8) 2 (16) 1 (7) 1 (9) 1 (9) 1 (9) 3 (24)
No injection 4 (37)
Numbers of pregnant animals with total numbers of embryos (d ).
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slightly elongated in the anterior direction, the lamella
structure was preserved and the total volume of the IO was
about 118% that of controls (untreated and DMSO
injected, Fig. 3). In contrast, the facial nucleus was
diminished in size versus the controls (Fig. 2).
Embryonic day 9–10 injection
atRA exposure over this period gave the most obvious
deformation of the IO. In the anteroposterior axis, the IO
elongated from its usual position to nearly reach the level
of the pontine nucleus (about 2.5 times the normal length)
(Fig. 2). The total volume of the IO was 143% of that of
the controls (Fig. 3). The overall shape of the posterior
portion of the IO (posterodorsal and posteroventral olive)
resembled that of the controls but was significantly
elongated over the anterior/posterior axis while the size
of each lamella appeared somewhat smaller (Fig. 2). In
contrast, the anterior region of the IO (anterior convoluted
olive and anteromedial olive) was severely disrupted andFig. 1. Wet weights of embryonic brains from atRA or control treated mice
taken from olfactory bulb to the level of the C1 nerve exit. Animals were
either treated with atRA at varying times (A) or treated with DMSO vehicle
(B). A significant decrease in wet weight was only evident following
treatment with atRA at embryonic day 8.the lamella structure was unidentifiable. The facial nucleus
appeared to be entirely absent (Fig. 2).
Single day injections on embryonic days 9, 10, or 11
In order to identify the day when atRA was most
effective, we injected atRA at either embryonic days 9,
10, or 11 (results not shown). Exposure to atRA at these
single time points did not induce as significant an effect as
the dual injections at embryonic day 9 and 10, although we
observed slight elongation (by a factor 1.5 compared to 2.5
when injected over consecutive days) and lamella disar-
rangement of IO in embryonic day 9 and in embryonic day
10 atRA injected animals. Therefore, prolonged exposure to
atRA over a 2-day period was necessary to induce the
maximum change in the IO. This would indicate that the
atRA sensitive molecular events that guide the normal
development of the IO take place over a period beyond that
of a single day.
Embryonic day 10–11 injection
The IO was anteroposteriorally elongated approximately
twofold and the changes were, in essence, the same as found
for atRA injections at embryonic day 9–10, with an elongated
posterior region of relatively normal organization and highly
disorganized anterior IO (Fig. 2). The magnitude of the
changes, however, was smaller and the total IO volume did
not differ from that of controls (Fig. 3). The shape of the facial
nucleus appeared elongated in the anteroposterior axis but
occupied a smaller area in each section.
Embryonic day 12–13 injection
Following this time of atRA treatment, the total IO
volume decreased to 68% of that of controls (Fig. 3).
Whereas the posterior IO exhibited relatively normal
morphology, the anterior IO was severely underdeveloped
in its lamella structure suggesting the majority of the cell
loss may be focused to the anterior IO (Fig. 4). The facial
nucleus appeared normal.
Embryonic day 14–15 injection
The change in the IO was similar to that following atRA
exposure at embryonic day 12–13 but with less irregularity
(Fig. 4). The total IO volume was about 84–90% of the
control (Fig. 3) and the facial nucleus did not exhibit an
obvious change.
Embryonic day 16–17 injection
No obvious change was observed (Fig. 4).
Fig. 2. Morphology of the IO and facial nucleus of embryonic day 18 mouse embryos following treatment of animals with atRA at embryonic days 8, 9–10,
10–11 or non-treatment with atRA. The IO (violet) and facial nucleus (red) are depicted using camera lucida drawings. A diagram of the anterior and posterior
IO subdivisions is shown at the bottom of the figure. The most pronounced effect of atRA resulted from treatment at embryonic day 9–10 leading to an
elongation of the IO and disappearance of the facial nucleus.
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The changes in the IO following extended atRA treat-
ment (Fig. 5) were similar to that observed after atRA
injections at embryonic day 12–13 (Fig. 4), including a
decline in the total volume to 68% (Fig. 3) of the control,
i.e. prolonged exposure to atRA did not augment the change
in the IO as compared to atRA exposure at embryonic day
12–13. When the long-term (more than 3 days) exposure to
atRA commenced at earlier stages, such as embryonic day 9,
the embryos died in utero.
Cell density
To determine whether cell density of the IO changed with
RA treatment, the average density was determined through-
out the IO in a single embryo from the control and RA
treatment groups. The cell density of the IO was unaltered by
atRA injection at any age when compared to a control. The
cell density of the atRA injected group (mean cell density
among sections F SD) was 8353 F 460/mm2 (embryonic
day 8), 7401 F 926/mm2 (embryonic day 9–10), 8111 F
844/mm2 (embryonic day 12–17), while the IO cell density
of untreated animals was 7849 F 1205/mm2. Therefore, the
volume change of the IO may largely reflect a change in cellnumber. Thus, following atRA injections at embryonic day 8
and embryonic day 9–10, the IO volume was likely elevated
because the total cell number increased, whereas injections at
embryonic day 12–13 resulted in a decrease in the total IO
cell number.
IO projection to the cerebellum
The axons of the IO project to the contralateral cerebellum
by crossing the ventral midline and it was determined
whether the projection pattern was preserved in the atRA
treated animal (Fig. 6). DiI was injected in one side of the
embryonic day 18 cerebellum and labeled cells were
observed in the IO. In normal animals, the projection is
contralateral, and this pattern was preserved in atRA-injected
animals even in severely deformed cases (embryonic day 9–
10 injection), i.e. ipsilateral cells were never labeled.
The expression pattern of OL-protocadherin and Brn 3a
In order to confirm the identity of the cell mass that we
identified as the IO, Brn 3a expression by these cells was
examined. Brn3a and 3b are expressed in the proliferating
cells along the ventral wall of the fourth ventricle, and in IO
Fig. 3. IO volume following atRA or control treatment calculated from tracings of the IO in serial sections. The mice were either treated with atRA at a range of
times (A) or by DMSO vehicle (B). As a result of two consecutive injections of atRA, the greatest increase in volume was evident following treatment at
embryonic day 9–10 while the largest decrease resulted from treatment at embryonic day 12–13. * designates that the change (either decrease or increase) was
significant compared to non-injected animals.
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Because Brn3b is down-regulated by RA (Turner et al.,
1994), while Brn3a is unaffected, Brn3a was used in the
study as a marker for the IO. In control animals, Brn3a
labeled the entire IO in the gestation day 18 embryo (Fig.
7A). In embryonic day 9/10 RA injected animals, the
anterior cell mass was also labeled (Fig. 7B), indicating that
the distribution of cells of the IO extended up to the level of
the pontine nucleus.
To investigate the events preceding this altered pattern of
Brn3a labeled IO cells, the medulla of younger embryos
(embryonic day 14) was examined following exposure to
RA at embryonic day 9–10 (Figs. 7C and D). In the
posterior-most portion of the IO in control animals, Brn3a
staining spread laterally from the midline, forming a
triangular shape with the base of the midline (Fig 7C). In
the atRA-injected animals, however, the morphology of the
IO changed with the migratory cell mass spreading laterally
in more anterior regions of the IO (Fig. 7D, arrowhead) as
well as being elongated rostrally (Fig. 7D, double-headed
arrow). The difference in the spread of the ventral Brn3a
positive cells following atRA exposure may suggest some
scattering of the migratory path of these cells along the
anteroposterior orientation, spreading the IO to an abnor-
mally high degree along this axis.
To further confirm that the atRA induced changes
identified by histological stain (Figs. 2, 4 and 5) werechanges in neurons of the IO, a second IO marker was
employed, OL-protocadherin (Olpc), a member of the
protocadherin family of adhesion proteins (Hirano et al.,
1999). Its mRNA transcript is detected in the anteromedial
olive (AMO) and posteroventral olive (PVO) from embry-
onic day 15 up to postnatal stages (Hirano et al., 1999) as
well as in the cerebellum, pontine nucleus, and the principle
trigeminal sensory nucleus. Using this probe, we could trace
the distribution of particular groups of IO neurons in atRA-
injected animals. In control animals, the expression pattern
of Olpc in the embryonic day 18 mouse by whole mount in
situ hybridization is shown in Figs. 8A and D. Following
atRA injections at embryonic day 8 (Fig. 8B), there was no
Olpc expression observed in the principle trigeminal sensory
nucleus, whereas, as found by histological analysis (Fig. 2),
the expression pattern in the IO was similar to that of
controls (Figs. 8A and D). After atRA injections at
embryonic day 9–10, in both PVO and AMO, the Olpc
positive region extended rostrally but with fainter expres-
sion in the AMO (Fig. 8C). A similar change, although to a
lesser extent, was seen after injection of atRA at embryonic
day 10–11 (Fig. 8E). The change of Olpc expression was
similar to that observed by cresyl violet staining (Fig. 2).
Treatment with atRA from embryonic day 12–17 had only a
minor influence on Olpc expression in the PVO but levels in
the AMO were again reduced (Fig. 8F). It is evident that the
changes in Olpc mRNA distribution (Fig. 8) parallel the
Fig. 4. Morphology of the IO and facial nucleus of embryonic day 18 mouse embryos following treatment of animals with atRA at embryonic days 12–13,
14–15, 16–17 or non-treatment with atRA. Inferior olive (violet) and facial nucleus (red) are depicted using camera lucida drawings. Abnormalities in the
IO were only observed following treatment at embryonic day 12–13, and these were similar to those following RA treatment at embryonic day 9–10 or 10–
11 but milder in extent.
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2, 4 and 5). Furthermore, the rostral distribution of both IO
markers Brn3a and Olpc after atRA treatment at embryonicFig. 5. Morphology of the IO and facial nucleus of embryonic day 18 mouse em
between embryonic day 12–17 or treatment with DMSO vehicle over the same peri
were similar to that observed after briefer atRA injections at embryonic day 12–1day 9–10 or embryonic day 10–11 implies that the
abnormally positioned rostral cell mass originally seen by
histological stain is derived from IO precursors.bryos following treatment of animals over an extended period with atRA
od. The changes in IO and facial nucleus following this lengthened exposure
3.
Fig. 6. Absence of change in the projection of the IO to the cerebellum in control (A and D) versus atRA treated embryos at embryonic day 9–10 (B and E) or
embryonic day 12–17 (C and F). DiI was injected unilaterally into the right cerebellar cortex in E18 animals after fixation (A–C), labeling the afferents to the
cerebellum from the IO as seen in coronal section. In coronal sections through the inferior olive (D–F), DiI labeled cells are only present in the left IO,
contralateral to the site of DiI (arrowheads mark the midline) and no labeled cells are evident on the ipsilateral side. Scale bar in panel C for panels A–C is
1 mm and in panel F for panels D–F is 300 Am.
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If excess atRA can promote expansion of the posterior
IO, it would be expected that a deficiency in atRA would
diminish this region of the IO. Although it is difficult to
generate vitamin A-deficient mice and the null mutant of
the RA synthesizing enzyme in the vicinity of the trunk,
RALDH2, is lethal by embryonic day 10.5 (Niederreither et
al., 1999), a well characterized vitamin A deficiency model
exists in the rat (Clagett-Dame and DeLuca, 2002; White et
al., 1998, 2000b). To provide an initial test of thisFig. 7. In situ hybridization of Brn 3a expression in the IO following atRA treatmen
was labeled by Brn 3a (A, marked by arrow). Following atRA treatment at emb
expression of Brn 3a (B, the spread of expression marked between the two arro
treatment with atRA at embryonic day 9–10 (D) as compared to the non-injected
arrows indicate the anteroposterior extent of IO and the arrowhead the most laterall
and C is 500 Am.hypothesis, embryonic day 21.5 rat embryos, depleted of
vitamin A (VAD) from embryonic day 10.5, were examined
in methyl green stained coronal sections (Fig. 9). These
were compared to vitamin A-sufficient embryos that had
been treated in a similar fashion but supplemented with
vitamin A from embryonic day 10.5 onwards. Two types of
control VAD embryos were examined, as detailed in the
methods (VAS #1 and #2) but morphology of the IO
seemed identical between the two and the comparison with
the VAD embryos in Fig. 9 was only made with VAS #2.
The convoluted anterior IO was normal in morphologyt. In the control embryonic day 18 mouse embryo (without injection), the IO
ryonic day 9–10, the elongation of the IO was evident from the extended
ws). When Brn 3a labeling was examined at embryonic day 14 following
animal (C), there was a significant expansion of the spread of Brn3a. The
y expanded position of ventrally migrating IO neurons. Scale bar in panels A
Fig. 8. In situ hybridization of OL-protocadherin (Olpc) expression in the embryonic day 18 IO following atRA treatment. In either the DMSO vehicle injected
control (A) or the uninjected control (D), Olpc is expressed in anterior (anteromedial olive, AMO) and posterior (posteroventral olive, PVO) divisions of the IO
(labeled by two arrows). Olpc is also present in the trigeminal senory nucleus (V). Treatment with atRA at embryonic day 8 resulted in little change in Olpc in
the IO (B) whereas treatment at embryonic day 9–10 resulted in significant elongation of the divisions of the IO (C). A less pronounced elongation resulted
from treatment at embryonic day 10–11 (E). Treatment with atRA at embryonic day 12–17 had only a minor influence on Olpc in the posteroventral olive but
expression in the anteromedial olive was significantly reduced. All the panels are the same magnification and panel C scale bar is 1 mm.
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the VAS #2 control (Figs. 9A, C). However, the posterior
IO was much smaller in the VAD treated animal (Figs. 9F,
H) compared to the control (Figs. 9E, G). At higher
magnification, the posteroventral olive is seen to be entirely
absent after VAD treatment (Fig. 9J) compared to the
control (Fig. 9I, pvO).Discussion
Effects of atRA excess and deficiency imply a role for RA in
IO development
atRA is essential for the early patterning of hindbrain
rhombomeres over the embryonic day 7.5 to 8.5 period in
the mouse (reviewed in (Begemann and Meyer, 2001;
Gavalas, 2002; McCaffery et al., 2003)) and starting at
embryonic day 9 in the rat (reviewed in (Clagett-Dame and
DeLuca, 2002)). atRA synthesized by RALDH2 in the
paraxial mesenchyme of the trunk diffuses to the posterior
hindbrain to organize rhombomeres 4–7 that will constitute
the myelencephalon. Excess atRA from embryonic day 7.5
to 8.5 in the mouse disturbs the normal balance of high
posterior and low anterior atRA and transforms anterior
rhombomeres to take on posterior characteristics. We have
previously identified a second critical period of hindbrain
atRA sensitivity in the mouse between embryonic 9.5 and
10.5 (Yamamoto et al., 2003). Exposure at this time results
in loss of the pontine nuclei in the anterior hindbrain due toaltered migration of neurons from the precerebellar primor-
dium. We now show that excess atRA has a very different
influence on more posterior hindbrain nuclei. Focusing on
the IO, we show that there is an elongation of this nucleus in
the anterior direction. Cells of the IO identified by Brn3a
expression were found to extend to the level of the pons.
The time of atRA exposure that results in this expansion of
the IO (embryonic day 9/10 or 10/11) is after the period at
which rhombomere identity is set. For instance, the genes
that mediate atRA induced posteriorization include Hoxb1
and Hoxb2 and anterior induction of neither Hoxb1, b2, or
b4 occur after embryonic day 9 (Conlon and Rossant, 1992).
This implies that the expansion of the IO is not simply a
switch of anterior rhombomeres to a posterior fate but is part
of a later event of determination.
Excess atRA results in an increase in IO cell number,
primarily in the posterior IO
The finding that the total IO volume increased with
apparently no change in cell density in the embryonic day 9/
10 atRA-injected embryo implies that the total number of IO
cells increased. The time of atRA injection that results in
elongation of the posterior IO, between embryonic days 9/10
and 10/11, is just before or at the earliest point when the cells
of the IO in the mouse become post-mitotic, at approx-
imately embryonic day 10–12 (based on the embryonic day
12–14 period of birth in the rat, (Altman and Bayer, 1997),
indicating that the period at which the progenitors are
sensitive to atRA is around their initial point of birth and
Fig. 9. Reduction of the posterior inferior olive in the vitamin A-deficient rat embryo. The morphology of the anterior inferior olive (aIO) is relatively normal
in both vitamin A-sufficient (VAS) conditions (A, C) as well as vitamin A-deficient (VAD) conditions (B, D). This contrasts with the posterior inferior olive
(pIO), which is normal in the VAS rat embryo (E, G) but is severely diminished in the VAD embyo (F, H). At higher magnification, the posterodorsal (pdO)
and the posteroventral (pvO) olive are clearly evident in the VAS embryo (I) but the posteroventral olive is entirely absent and the posterodorsal olive
diminished in the VAD embryo (J). Panels A–H are the same magnification and panel H scale bar is 1 mm. Panels I and J are the same magnification and
panel J scale bar is 200 Am.
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teratological effects of atRA on the hindbrain have focused
on the embryonic day 7.5 to 8.5 period when atRA disrupts
rhombomere organization. However, the time of exposure
used in this study was subsequent to the phase of
rhombomere specification. Indeed, atRA exposure at embry-
onic day 8 has only a relatively mild influence on the
morphology of the IO. It is evident that the hindbrain is stillsensitive to atRA after embryonic day 9.5. If cells in the
posterior hindbrain respond to atRA, this may suggest that
endogenous atRA influences their normal development.
Certainly, atRA is generated in the vicinity of the posterior
hindbrain by the synthetic enzyme RALDH2 in mesenchyme
along the trunk (Niederreither et al., 1997; Zhang et al.,
2003). Although mesenchymal RALDH2 expression does
not extend to parallel the posterior hindbrain birthplace of the
M. Yamamoto et al. / Developmental Biology 280 (2005) 421–433 431IO, i.e. rhombomeres 7 and 8 (Ambrosiani et al., 1996;
Marin and Puelles, 1995), it has been shown by Smith et al.
(Smith et al., 2001) that atRA diffuses anteriorly and is
transcriptionally active in these posterior rhombomeres at
least up to embryonic day 10.5. Thus, it is likely that atRA
continues to play a function in posterior hindbrain develop-
ment beyond embryonic day 8.5 and the IO and its
progenitors will be exposed to endogenous RA. Results
using a transgenic RA reporter mouse line indicate that
subregions of the IO respond to endogenous RA (Zhang et
al., 2003). The closer proximity of the posterior IO to the
posterior source of RA from RALDH2 in the trunk
mesenchyme might imply that this region of the IO has the
highest requirement for RA. It is possible then that RA may
promote specification of the fate of these neurons or may act
as a trophic factor for posterior IO cells—excess RA applied
at embryonic days 9 and 10 may lead to an over-generation
or switch in fate of posterior IO cells and increase in number
of cells. Supporting this hypothesis is the loss of the
posteroventral olive and much of the posterodorsal olive
when the substrate for atRA, vitamin A, is depleted in the rat
after embryonic day 10.5 (equivalent to approximately day
9.0 in the mouse). Vitamin A depletion will result in loss of
atRA at the time the inferior olive progenitors are born in the
rat at embryonic days 12–14 (Altman and Bayer, 1997),
indicating that a vitamin A product, presumably atRA, is
necessary for the formation of the posterior IO.
Excess RA interferes with the morphology of the anterior IO
Regional differences in the sensitivity of the IO to atRA
not only exist between the anterior versus posterior IO but
also in the dorsal versus ventral axis. On exposure to
excess atRA, the expansion of the IO predominantly occurs
in the posteroventral segment whereas the posterodorsal
olive can no longer be distinguished. When atRA is
diminished in the VAD rat embryos, it is the posteroventral
olive that is entirely eliminated. It may be relevant that the
lamella of the anterior IO which, like the posterodorsal
olive, is born at around embryonic day 10–11 in the mouse
(based on the embryonic day 12–13 period of birth in the
rat, (Altman and Bayer, 1997)), is also severely diminished
in size after exposure to excess atRA. Indeed, the anterior
lamellar structure of the IO shows greatest sensitivity to
atRA at embryonic day 10–11 suggesting that atRA
interferes with differentiation of these cells at the point
they become post-mitotic.
Other hindbrain abnormalities result from excess atRA
The increase in cell number of the IO does not account
for its expansion along the anterior axis by a factor of 2–3
times that of the control animal implying that there are also
abnormalities in the migration of the cells of the posterior
IO, in particular along the anteroposterior axis. A change in
the migratory pattern along this axis is one example of asimilarity with the effects of atRA on the pontine nuclei
(Yamamoto et al., 2003) in which case the normally
compact stream of cells that migrate to form the pontine
nuclei scatter over the anterior medulla.
The teratogenic effect of atRA on precerebellar nuclei
such as the IO and pontine nuclei does not imply that RA
only influences this subset of hindbrain neurons. Exposure
to atRA at embryonic day 9–10 resulted in complete loss of
the facial nucleus, the neurons of which derive from the
floor of the fourth ventricle (Altman and Bayer, 1980;
Auclair et al., 1996). The progenitors migrate caudally from
their birthplace and it is interesting that exposure at E10–11
leads to elongation of this structure, suggesting RA may
influence this migration. More intensive study of this
nucleus however will be necessary to understand these
two quite different effects of atRA but they imply that RA
influences the facial nucleus. A recent study on zebrafish
demonstrated that a deficiency of atRA, at a time that does
not influence rhombomere patterning, interferes with
migration of facial branchiomotor neurons (Linville et al.,
2004). It is probable then that the development of the facial
nucleus, like the IO, is regulated by endogenously synthe-
sized atRA. In the zebrafish, the facial branchiomotor
neurons depend on atRA synthesized by RALDH2 in the
paraxial mesoderm (Linville et al., 2004) but in the chick the
enzyme itself is expressed transiently in the facial/vestibu-
locochlear nucleus, so species difference may exist regard-
ing the source of RA. Other derivatives of ventricular
progenitors are also potential targets for regulation by RA,
including the vagal nerve (Begemann et al., 2004; Linville
et al., 2004) in which branchiomotor neurons are reduced in
the atRA-deficient zebrafish and the vestibular nerve, which
expresses RALDH2 in the mouse (Zhang et al., 2003).
These will also of interest for future investigation comparing
the effects of atRA excess and deficiency after the period of
rhombomere patterning.
RA teratogenicity in the human hindbrain
Although animal models of atRA teratogenicity have
emphasized the dramatic effects of early (embryonic day 7
and 8) exposure, it is notable that the teratogenic effects of 13-
cis RA on the human brain, specifically abnormalities of the
pontine nuclei and inferior olive (Lammer and Armstrong,
1992), more resemble the effects we describe following atRA
exposure at embryonic day 9–10. An explanation for this is
that early exposure of the human embryo to 13-cis RA will
result in severe abnormalities resulting in early embryonic
death whereas later exposure, resulting in pontine nuclei and
inferior olive malformations (Yamamoto et al., 2003), may
not result in abnormalities so severe as to trigger early
embryonic death and hence these changes are more likely to
be seen in the fetus. Postnatal death, however, frequently
occurs presumably due to medullary malformations and
degradation in the control of the autonomic nervous system.
Similarities exist between atRA exposure, during these later
M. Yamamoto et al. / Developmental Biology 280 (2005) 421–433432development stages, and several human developmental brain
disorders. One is Joubert’s syndrome, a relatively rare,
autosomal-recessive disease defined by vermal agenesis
and malformation of multiple brainstem structures, together
with abnormal breathing patterns or abnormal eye move-
ments (ten Donkelaar et al., 2000; Yachnis and Rorke, 1999).
A second disorder is fetal alcohol syndrome, which has also
been reported to include abnormalities in the cerebellar
vermis (Archibald et al., 2001; Pierce et al., 1993), brainstem
(Johnson et al., 1996), and inferior olive (Johnson et al., 1996;
Swayze et al., 1997). It has been suggested that one
mechanism by which alcohol interferes with embryonic
development occurs through disruption of atRA signaling
(Duester, 1991; Pullarkat, 1991; Zachman and Grummer,
1998). Our results suggest that the human gestation period
equivalent to mouse embryonic day 9–10 will be a sensitive
time for genetic or teratogenic disruption of hindbrain
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